$28.00
-0.80[-2.78%]
Last update: 12:44PM Get Real Time Here
Immunovant
(NASDAQ:IMVT)Immunovant Stock (NASDAQ:IMVT), Earnings Estimates, EPS, and Revenue
Immunovant reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 20
EPS Estimate
$-0.450
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Immunovant using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/20/2024 | AM | IMVT | Q4 | -$0.46 | -$0.45 | — | — | $0.00 | — | — | — | Get Alert |
| 02/12/2024 | AM | IMVT | Q3 | -$0.49 | -$0.43 | -$0.36 | 16.28% | $0.00 | — | $0.00 | — | Get Alert |
| 11/09/2023 | AM | IMVT | Q2 | -$0.41 | -$0.48 | -$0.45 | 6.25% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2023 | AM | IMVT | Q1 | -$0.35 | -$0.45 | -$0.57 | -26.67% | $0.00 | — | $0.00 | — | Get Alert |
| 05/22/2023 | AM | IMVT | Q4 | -$0.41 | -$0.43 | -$0.46 | -6.98% | $0.00 | — | $0.00 | — | Get Alert |
| 02/03/2023 | AM | IMVT | Q3 | -$0.36 | -$0.39 | -$0.49 | -25.64% | $0.00 | — | $0.00 | — | Get Alert |
| 11/04/2022 | AM | IMVT | Q2 | -$0.35 | -$0.39 | -$0.41 | -5.13% | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2022 | AM | IMVT | Q1 | -$0.31 | -$0.40 | -$0.35 | 12.50% | $0.00 | — | $0.00 | — | Get Alert |
| 06/08/2022 | AM | IMVT | Q4 | -$0.29 | -$0.38 | -$0.41 | -7.89% | $0.00 | — | $0.00 | — | Get Alert |
| 02/04/2022 | AM | IMVT | Q3 | -$0.32 | -$0.33 | -$0.36 | -9.09% | $0.00 | — | $0.00 | — | Get Alert |
| 11/05/2021 | AM | IMVT | Q2 | -$0.25 | -$0.30 | -$0.35 | -16.67% | $0.00 | — | $0.00 | — | Get Alert |
| 08/09/2021 | AM | IMVT | Q1 | -$0.38 | -$0.30 | -$0.31 | -3.33% | $0.00 | — | $0.00 | — | Get Alert |
| 06/01/2021 | AM | IMVT | Q4 | -$0.38 | -$0.32 | -$0.29 | 9.38% | $0.00 | — | $0.00 | — | Get Alert |
| 02/16/2021 | AM | IMVT | Q3 | -$0.28 | — | -$0.32 | — | — | — | $0.00 | — | Get Alert |
| 11/12/2020 | AM | IMVT | Q2 | -$0.38 | -$0.34 | -$0.25 | 26.47% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2020 | AM | IMVT | Q1 | — | — | -$0.38 | — | — | — | $0.00 | — | Get Alert |
| 06/29/2020 | AM | IMVT | Q4 | — | — | -$0.38 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Immunovant (NASDAQ:IMVT) reporting earnings?
Immunovant (IMVT) is scheduled to report earnings on May 20, 2024. The last reported earnings were for reported on February 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Immunovant (NASDAQ:IMVT)?
The Actual EPS was $-0.36, which beat the estimate of $-0.43.
What were Immunovant’s (NASDAQ:IMVT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.